Lidocaine Prilocaine Spray in Reducing Pain During Hysterosalpingography in Women With Primary Infertility
NCT ID: NCT06769204
Last Updated: 2025-01-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
PHASE3
90 participants
INTERVENTIONAL
2025-02-10
2025-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Endocervical Lidocaine Spray for Pain Control During Office Hysteroscopy
NCT03382743
EMLA Cream in Hysteroscopy Practice
NCT02640183
Comparative Efficacy of Lidocaine Spray Versus Vaginal Dinoprostone in IUD Insertion
NCT04339361
Efficacy Study of Topical Application of Lidacaine Spray Prior to IUD Insertion
NCT01496105
Cervical Lidocaine-Prilocaine Cream vs Glyceryl Trinitrate Cream in Nulliparous Women With LNG-IUD Insertion
NCT04355598
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
lidocaine prilocaine
EMLA SPRAY
2 puffs of lidocaine-prilocaine spray into the cervix and cervical canal 5 minutes before the procedure
placebo
Placebo
2 puffs of saline into the cervix and cervical canal 5 minutes before the procedure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EMLA SPRAY
2 puffs of lidocaine-prilocaine spray into the cervix and cervical canal 5 minutes before the procedure
Placebo
2 puffs of saline into the cervix and cervical canal 5 minutes before the procedure
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Current pregnancy or suspicion of pregnancy.
* Active pelvic inflammatory disease or history of severe pelvic infections within the last 6 months.
* Use of systemic analgesics, sedatives, or anesthetics within 24 hours prior to the procedure.
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Samy aly ashour
professor
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LP SPRAY HSG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.